Repligen | RGEN - Capitalização De Mercado

Preço das Ações
123.46
Mudança Diária
-2.97 -2.35%
Mensal
3.07%
Anual
0.18%
Q2 Previsão
114.76




Capitalização De Mercado Alterar Data
Agilent USD 37.86B 3.64B 2025-12
Align Technology USD 12.28B 1.07B 2026-03
Bio Techne USD 7.45B 723M 2026-05
BioMarin Pharmaceutical USD 10.57B 290M 2026-05
Bristol-Myers Squibb USD 123.83B 14.02B 2026-03
Bruker USD 6.41B 915M 2026-05
Charles River Laboratories USD 9.29B 1.44B 2026-05
Danaher USD 128.46B 33.24B 2026-03
Dentsply International USD 2.36B 41M 2026-05
General Electric Aerospace USD 296.49B 28.42B 2026-03
Henry Schein USD 9.55B 1.28B 2026-05
Illumina USD 17.88B 2.74B 2026-03
IQVIA Holdings USD 32.02B 3.39B 2026-05
Mettler Toledo International USD 28.34B 2.8B 2026-05
Myriad Genetics USD 575M 98M 2025-12
OraSure Technologies USD 174M 61M 2025-12
Pacific Biosciences Of California USD 565M 180M 2025-12
Pfizer USD 149.77B 4.04B 2026-05
Repligen USD 7.01B 360M 2026-05
Revvity USD 11.4B 1.46B 2026-05
Standard Biotools USD 492M 5M 2025-12
Thermo Fisher Scientific USD 182.66B 35.04B 2026-03
Waters USD 20.29B 9.57B 2026-05
West Pharmaceutical Services USD 18.07B 1.73B 2026-03